| Cyclosporine | Approved Investigational Vet Approved | NAGLU | 4669 |
downregulated | Cyclosporine results in decreased expression of NAGLU mRNA | 17q21.2 | |
| Cyclosporine | Approved Investigational Vet Approved | NAGPA | 51172 |
downregulated | Cyclosporine results in decreased expression of NAGPA mRNA | 16p13.3 | |
| Cyclosporine | Approved Investigational Vet Approved | NAGS | 162417 |
upregulated | Cyclosporine results in increased expression of NAGS mRNA | 17q21.31 | |
| Cyclosporine | Approved Investigational Vet Approved | NAIF1 | 203245 |
upregulated | Cyclosporine results in increased expression of NAIF1 mRNA | 9q34.11 | |
| Cyclosporine | Approved Investigational Vet Approved | NAMPT | 10135 |
upregulated | Cyclosporine results in increased expression of NAMPT mRNA | 7q22.3 | |
| Cyclosporine | Approved Investigational Vet Approved | NANOS1 | 340719 |
downregulated | Cyclosporine results in decreased expression of NANOS1 mRNA | 10q26.11 | |
| Cyclosporine | Approved Investigational Vet Approved | NANOS1 | 340719 |
upregulated | Cyclosporine results in increased expression of NANOS1 mRNA | 10q26.11 | |
| Cyclosporine | Approved Investigational Vet Approved | NANS | 54187 |
upregulated | Cyclosporine results in increased expression of NANS mRNA | 9q22.33 | |
| Cyclosporine | Approved Investigational Vet Approved | NAP1L1 | 4673 |
upregulated | Cyclosporine results in increased expression of NAP1L1 mRNA | 12q21.1 | |
| Cyclosporine | Approved Investigational Vet Approved | NAP1L3 | 4675 |
downregulated | Cyclosporine results in decreased expression of NAP1L3 mRNA | Xq21.32 | |
| Cyclosporine | Approved Investigational Vet Approved | NAP1L5 | 266812 |
downregulated | Cyclosporine results in decreased expression of NAP1L5 mRNA | 4q22.1 | |
| Cyclosporine | Approved Investigational Vet Approved | NAPEPLD | 222236 |
downregulated | Cyclosporine results in decreased expression of NAPEPLD mRNA | 7q22.1 | |
| Cyclosporine | Approved Investigational Vet Approved | NAPG | 8774 |
upregulated | Cyclosporine results in increased expression of NAPG mRNA | 18p11.22 | |
| Cyclosporine | Approved Investigational Vet Approved | NAPRT | 93100 |
downregulated | Cyclosporine results in decreased expression of NAPRT mRNA | 8q24.3 | |
| Cyclosporine | Approved Investigational Vet Approved | NARF | 26502 |
downregulated | Cyclosporine results in decreased expression of NARF mRNA | 17q25.3 | |
| Cyclosporine | Approved Investigational Vet Approved | NARS | 4677 |
upregulated | Cyclosporine results in increased expression of NARS mRNA | 18q21.31 | |
| Cyclosporine | Approved Investigational Vet Approved | NARS2 | 79731 |
downregulated | Cyclosporine results in decreased expression of NARS2 mRNA | 11q14.1 | |
| Cyclosporine | Approved Investigational Vet Approved | NASP | 4678 |
downregulated | Cyclosporine results in decreased expression of NASP mRNA | 1p34.1 | |
| Cyclosporine | Approved Investigational Vet Approved | NAT1 | 9 |
downregulated | Cyclosporine results in decreased expression of NAT1 mRNA | 8p22 | |
| Cyclosporine | Approved Investigational Vet Approved | NAT14 | 57106 |
downregulated | Cyclosporine results in decreased expression of NAT14 mRNA | 19q13.42 | |
| Cyclosporine | Approved Investigational Vet Approved | NAT2 | 10 |
downregulated | Cyclosporine results in decreased expression of NAT2 mRNA | 8p22 | |
| Cyclosporine | Approved Investigational Vet Approved | NAT6 | 24142 |
downregulated | Cyclosporine results in decreased expression of NAT6 mRNA | 3p21.31 | |
| Cyclosporine | Approved Investigational Vet Approved | NAT8 | 9027 |
downregulated | Cyclosporine results in decreased expression of NAT8 mRNA | 2p13.1 | |
| Cyclosporine | Approved Investigational Vet Approved | NAT9 | 26151 |
upregulated | Cyclosporine results in increased expression of NAT9 mRNA | 17q25.2 | |
| Cyclosporine | Approved Investigational Vet Approved | NAV2 | 89797 |
upregulated | Cyclosporine results in increased expression of NAV2 mRNA | 11p15.1 | |